Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Herpesvirus 2, Human | 3 | 2019 | 137 | 0.84 | Why? |
| Herpesvirus 1, Human | 3 | 2019 | 286 | 0.82 | Why? |
| Herpes Simplex | 3 | 2019 | 272 | 0.81 | Why? |
| Vaccines, Edible | 1 | 2019 | 5 | 0.80 | Why? |
| Skin Absorption | 1 | 2019 | 18 | 0.79 | Why? |
| DNA Viruses | 1 | 2021 | 184 | 0.76 | Why? |
| Flavanones | 1 | 2020 | 141 | 0.76 | Why? |
| Interferon beta-1a | 1 | 2020 | 316 | 0.67 | Why? |
| Herpesviridae | 1 | 2017 | 100 | 0.61 | Why? |
| Ultraviolet Rays | 2 | 2021 | 1272 | 0.58 | Why? |
| Herpesviridae Infections | 1 | 2017 | 172 | 0.57 | Why? |
| Ozone | 1 | 2021 | 757 | 0.52 | Why? |
| RNA Viruses | 1 | 2021 | 824 | 0.51 | Why? |
| Virus Inactivation | 1 | 2021 | 1139 | 0.47 | Why? |
| Lung Injury | 1 | 2021 | 919 | 0.45 | Why? |
| Antibodies, Monoclonal | 3 | 2018 | 8041 | 0.39 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.38 | Why? |
| Disinfection | 1 | 2021 | 2912 | 0.35 | Why? |
| Dendritic Cells | 3 | 2021 | 1330 | 0.35 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.31 | Why? |
| Pharmaceutical Preparations | 1 | 2020 | 1897 | 0.30 | Why? |
| Virus Replication | 5 | 2020 | 14331 | 0.30 | Why? |
| Virus Diseases | 1 | 2021 | 3779 | 0.25 | Why? |
| Vero Cells | 5 | 2020 | 14117 | 0.25 | Why? |
| Virus Internalization | 4 | 2019 | 7921 | 0.25 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.24 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.24 | Why? |
| Viral Envelope Proteins | 3 | 2019 | 3539 | 0.22 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.20 | Why? |
| Vaccines | 1 | 2019 | 3692 | 0.20 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.20 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.18 | Why? |
| Gene Transfer Techniques | 1 | 2019 | 134 | 0.18 | Why? |
| Neutralization Tests | 4 | 2021 | 6698 | 0.18 | Why? |
| Interferons | 2 | 2021 | 2885 | 0.17 | Why? |
| Animals | 9 | 2021 | 78931 | 0.16 | Why? |
| Immunity, Mucosal | 1 | 2019 | 426 | 0.15 | Why? |
| Viral Plaque Assay | 1 | 2017 | 381 | 0.15 | Why? |
| Cross Protection | 1 | 2017 | 373 | 0.14 | Why? |
| Arthritis, Psoriatic | 1 | 2021 | 625 | 0.14 | Why? |
| HEK293 Cells | 2 | 2019 | 8394 | 0.14 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.13 | Why? |
| Immunity, Humoral | 2 | 2019 | 4849 | 0.13 | Why? |
| Eye | 1 | 2017 | 374 | 0.12 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.12 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.11 | Why? |
| Administration, Oral | 1 | 2019 | 2340 | 0.11 | Why? |
| Interferon Type I | 2 | 2021 | 2789 | 0.11 | Why? |
| Virion | 1 | 2019 | 1444 | 0.11 | Why? |
| Italy | 5 | 2021 | 38444 | 0.10 | Why? |
| Immunoglobulin kappa-Chains | 1 | 2009 | 12 | 0.10 | Why? |
| Mice | 3 | 2020 | 21357 | 0.10 | Why? |
| Mice, Inbred C57BL | 2 | 2020 | 5542 | 0.10 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.10 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Clinical Trials as Topic | 2 | 2019 | 7330 | 0.09 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.09 | Why? |
| Nutritional Status | 1 | 2018 | 1403 | 0.09 | Why? |
| Signal Transduction | 2 | 2021 | 7207 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.08 | Why? |
| B-Lymphocyte Subsets | 1 | 2009 | 372 | 0.08 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.08 | Why? |
| Humans | 21 | 2021 | 930598 | 0.08 | Why? |
| Autoantigens | 1 | 2009 | 388 | 0.08 | Why? |
| Antigens, Bacterial | 1 | 2009 | 330 | 0.08 | Why? |
| Immunity, Cellular | 1 | 2019 | 3614 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.07 | Why? |
| Communicable Diseases | 1 | 2019 | 2148 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2019 | 4624 | 0.06 | Why? |
| Lung | 3 | 2021 | 31049 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Surgical Procedures, Operative | 1 | 2018 | 2662 | 0.06 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.06 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Child | 2 | 2021 | 70012 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Female | 7 | 2021 | 380317 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Poly I-C | 1 | 2020 | 176 | 0.05 | Why? |
| Adult | 5 | 2021 | 244371 | 0.05 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Molecular Typing | 1 | 2020 | 280 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Male | 7 | 2021 | 367725 | 0.05 | Why? |
| Neuropilin-1 | 1 | 2021 | 284 | 0.05 | Why? |
| Cell Proliferation | 2 | 2020 | 1973 | 0.04 | Why? |
| Infant | 1 | 2021 | 30274 | 0.04 | Why? |
| Likelihood Functions | 1 | 2020 | 719 | 0.04 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.04 | Why? |
| Toll-Like Receptor 3 | 1 | 2020 | 391 | 0.04 | Why? |
| Aged | 5 | 2021 | 215776 | 0.04 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.04 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.04 | Why? |
| Disulfides | 1 | 2017 | 161 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.04 | Why? |
| Evolution, Molecular | 1 | 2009 | 3691 | 0.04 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.04 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.04 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2018 | 907 | 0.04 | Why? |
| Technology | 1 | 2021 | 812 | 0.03 | Why? |
| Drug Synergism | 1 | 2018 | 833 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2020 | 1638 | 0.03 | Why? |
| Coronary Artery Disease | 1 | 2009 | 2570 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Epitope Mapping | 1 | 2017 | 1240 | 0.03 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Protein Multimerization | 1 | 2017 | 1336 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Staphylococcal Infections | 1 | 2020 | 1099 | 0.03 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.02 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2020 | 3239 | 0.02 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Clone Cells | 1 | 2009 | 312 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Malnutrition | 1 | 2018 | 932 | 0.02 | Why? |
| Multigene Family | 1 | 2009 | 377 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.02 | Why? |
| Protein Conformation | 1 | 2017 | 4386 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Models, Molecular | 1 | 2017 | 7616 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
Clementi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(138)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_